Logo image of IOSP

INNOSPEC INC (IOSP) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:IOSP - US45768S1050 - Common Stock

74.01 USD
-0.84 (-1.12%)
Last: 12/4/2025, 8:00:03 PM
74.01 USD
0 (0%)
After Hours: 12/4/2025, 8:00:03 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to IOSP. IOSP was compared to 81 industry peers in the Chemicals industry. While IOSP has a great health rating, its profitability is only average at the moment. IOSP has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year IOSP was profitable.
In the past year IOSP had a positive cash flow from operations.
IOSP had positive earnings in each of the past 5 years.
IOSP had a positive operating cash flow in each of the past 5 years.
IOSP Yearly Net Income VS EBIT VS OCF VS FCFIOSP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

1.2 Ratios

IOSP's Return On Assets of -0.07% is in line compared to the rest of the industry. IOSP outperforms 50.62% of its industry peers.
IOSP's Return On Equity of -0.09% is in line compared to the rest of the industry. IOSP outperforms 54.32% of its industry peers.
IOSP has a Return On Invested Capital of 9.58%. This is amongst the best in the industry. IOSP outperforms 81.48% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IOSP is significantly above the industry average of 6.15%.
Industry RankSector Rank
ROA -0.07%
ROE -0.09%
ROIC 9.58%
ROA(3y)6.16%
ROA(5y)5.29%
ROE(3y)9.29%
ROE(5y)7.99%
ROIC(3y)11.29%
ROIC(5y)9.61%
IOSP Yearly ROA, ROE, ROICIOSP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

In the last couple of years the Profit Margin of IOSP has declined.
With a Operating Margin value of 9.31%, IOSP perfoms like the industry average, outperforming 53.09% of the companies in the same industry.
In the last couple of years the Operating Margin of IOSP has remained more or less at the same level.
IOSP has a Gross Margin of 28.01%. This is comparable to the rest of the industry: IOSP outperforms 51.85% of its industry peers.
IOSP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.31%
PM (TTM) N/A
GM 28.01%
OM growth 3Y3.11%
OM growth 5Y-0.56%
PM growth 3Y-32.51%
PM growth 5Y-23.61%
GM growth 3Y0.12%
GM growth 5Y-0.92%
IOSP Yearly Profit, Operating, Gross MarginsIOSP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IOSP is creating some value.
IOSP has more shares outstanding than it did 1 year ago.
The number of shares outstanding for IOSP has been increased compared to 5 years ago.
IOSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IOSP Yearly Shares OutstandingIOSP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
IOSP Yearly Total Debt VS Total AssetsIOSP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 4.77 indicates that IOSP is not in any danger for bankruptcy at the moment.
IOSP's Altman-Z score of 4.77 is amongst the best of the industry. IOSP outperforms 92.59% of its industry peers.
IOSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.77
ROIC/WACC1.1
WACC8.7%
IOSP Yearly LT Debt VS Equity VS FCFIOSP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

IOSP has a Current Ratio of 2.78. This indicates that IOSP is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of IOSP (2.78) is better than 77.78% of its industry peers.
IOSP has a Quick Ratio of 1.81. This is a normal value and indicates that IOSP is financially healthy and should not expect problems in meeting its short term obligations.
IOSP's Quick ratio of 1.81 is fine compared to the rest of the industry. IOSP outperforms 74.07% of its industry peers.
Industry RankSector Rank
Current Ratio 2.78
Quick Ratio 1.81
IOSP Yearly Current Assets VS Current LiabilitesIOSP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

IOSP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.11%.
Measured over the past 5 years, IOSP shows a small growth in Earnings Per Share. The EPS has been growing by 2.75% on average per year.
IOSP shows a decrease in Revenue. In the last year, the revenue decreased by -4.49%.
IOSP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.05% yearly.
EPS 1Y (TTM)-16.11%
EPS 3Y7.65%
EPS 5Y2.75%
EPS Q2Q%-17.04%
Revenue 1Y (TTM)-4.49%
Revenue growth 3Y7.55%
Revenue growth 5Y4.05%
Sales Q2Q%-0.34%

3.2 Future

IOSP is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.47% yearly.
Based on estimates for the next years, IOSP will show a small growth in Revenue. The Revenue will grow by 2.57% on average per year.
EPS Next Y-9.9%
EPS Next 2Y1.94%
EPS Next 3Y2.47%
EPS Next 5YN/A
Revenue Next Year-1.4%
Revenue Next 2Y2.78%
Revenue Next 3Y2.57%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IOSP Yearly Revenue VS EstimatesIOSP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
IOSP Yearly EPS VS EstimatesIOSP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.94 indicates a correct valuation of IOSP.
IOSP's Price/Earnings ratio is a bit cheaper when compared to the industry. IOSP is cheaper than 71.60% of the companies in the same industry.
IOSP is valuated rather cheaply when we compare the Price/Earnings ratio to 26.41, which is the current average of the S&P500 Index.
IOSP is valuated reasonably with a Price/Forward Earnings ratio of 11.87.
IOSP's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. IOSP is cheaper than 67.90% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.40, IOSP is valued rather cheaply.
Industry RankSector Rank
PE 13.94
Fwd PE 11.87
IOSP Price Earnings VS Forward Price EarningsIOSP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

75.31% of the companies in the same industry are more expensive than IOSP, based on the Enterprise Value to EBITDA ratio.
IOSP's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 66.69
EV/EBITDA 7.49
IOSP Per share dataIOSP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)5.08
EPS Next 2Y1.94%
EPS Next 3Y2.47%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.33%, IOSP has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.88, IOSP pays a bit more dividend than its industry peers.
IOSP's Dividend Yield is comparable with the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 2.33%

5.2 History

On average, the dividend of IOSP grows each year by 8.78%, which is quite nice.
IOSP has paid a dividend for at least 10 years, which is a reliable track record.
IOSP has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)8.78%
Div Incr Years11
Div Non Decr Years11
IOSP Yearly Dividends per shareIOSP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of IOSP are negative and hence is the payout ratio. IOSP will probably not be able to sustain this dividend level.
IOSP's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP-3383.33%
EPS Next 2Y1.94%
EPS Next 3Y2.47%
IOSP Yearly Income VS Free CF VS DividendIOSP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

INNOSPEC INC

NASDAQ:IOSP (12/4/2025, 8:00:03 PM)

After market: 74.01 0 (0%)

74.01

-0.84 (-1.12%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-16 2026-02-16/amc
Inst Owners99.5%
Inst Owner Change-0.33%
Ins Owners1%
Ins Owner Change0.05%
Market Cap1.83B
Revenue(TTM)1.79B
Net Income(TTM)-1.20M
Analysts82.22
Price Target109.65 (48.16%)
Short Float %1.82%
Short Ratio2.03
Dividend
Industry RankSector Rank
Dividend Yield 2.33%
Yearly Dividend1.56
Dividend Growth(5Y)8.78%
DP-3383.33%
Div Incr Years11
Div Non Decr Years11
Ex-Date11-18 2025-11-18 (0.87)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.56%
Min EPS beat(2)-2.48%
Max EPS beat(2)3.59%
EPS beat(4)2
Avg EPS beat(4)2.06%
Min EPS beat(4)-2.48%
Max EPS beat(4)8.85%
EPS beat(8)4
Avg EPS beat(8)2.71%
EPS beat(12)6
Avg EPS beat(12)2.32%
EPS beat(16)10
Avg EPS beat(16)6.92%
Revenue beat(2)0
Avg Revenue beat(2)-1.4%
Min Revenue beat(2)-1.84%
Max Revenue beat(2)-0.96%
Revenue beat(4)1
Avg Revenue beat(4)-1.75%
Min Revenue beat(4)-6.47%
Max Revenue beat(4)2.28%
Revenue beat(8)2
Avg Revenue beat(8)-2.68%
Revenue beat(12)4
Avg Revenue beat(12)-2.35%
Revenue beat(16)8
Avg Revenue beat(16)0.49%
PT rev (1m)-4.44%
PT rev (3m)-6.52%
EPS NQ rev (1m)-12.88%
EPS NQ rev (3m)-18.78%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.46%
Revenue NQ rev (1m)-4.23%
Revenue NQ rev (3m)-5.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.76%
Valuation
Industry RankSector Rank
PE 13.94
Fwd PE 11.87
P/S 1.03
P/FCF 66.69
P/OCF 17.87
P/B 1.41
P/tB 2.2
EV/EBITDA 7.49
EPS(TTM)5.31
EY7.17%
EPS(NY)6.24
Fwd EY8.43%
FCF(TTM)1.11
FCFY1.5%
OCF(TTM)4.14
OCFY5.59%
SpS72.2
BVpS52.34
TBVpS33.65
PEG (NY)N/A
PEG (5Y)5.08
Graham Number79.08
Profitability
Industry RankSector Rank
ROA -0.07%
ROE -0.09%
ROCE 11.54%
ROIC 9.58%
ROICexc 11.8%
ROICexgc 19.5%
OM 9.31%
PM (TTM) N/A
GM 28.01%
FCFM 1.54%
ROA(3y)6.16%
ROA(5y)5.29%
ROE(3y)9.29%
ROE(5y)7.99%
ROIC(3y)11.29%
ROIC(5y)9.61%
ROICexc(3y)13.47%
ROICexc(5y)11.26%
ROICexgc(3y)22.5%
ROICexgc(5y)18.82%
ROCE(3y)13.59%
ROCE(5y)11.57%
ROICexgc growth 3Y13.46%
ROICexgc growth 5Y3.02%
ROICexc growth 3Y11.53%
ROICexc growth 5Y3.76%
OM growth 3Y3.11%
OM growth 5Y-0.56%
PM growth 3Y-32.51%
PM growth 5Y-23.61%
GM growth 3Y0.12%
GM growth 5Y-0.92%
F-Score5
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 166.52%
Cap/Sales 4.2%
Interest Coverage 250
Cash Conversion 48.49%
Profit Quality N/A
Current Ratio 2.78
Quick Ratio 1.81
Altman-Z 4.77
F-Score5
WACC8.7%
ROIC/WACC1.1
Cap/Depr(3y)148.38%
Cap/Depr(5y)120.26%
Cap/Sales(3y)3.16%
Cap/Sales(5y)2.92%
Profit Quality(3y)155.47%
Profit Quality(5y)185.88%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.11%
EPS 3Y7.65%
EPS 5Y2.75%
EPS Q2Q%-17.04%
EPS Next Y-9.9%
EPS Next 2Y1.94%
EPS Next 3Y2.47%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.49%
Revenue growth 3Y7.55%
Revenue growth 5Y4.05%
Sales Q2Q%-0.34%
Revenue Next Year-1.4%
Revenue Next 2Y2.78%
Revenue Next 3Y2.57%
Revenue Next 5YN/A
EBIT growth 1Y-8.06%
EBIT growth 3Y10.9%
EBIT growth 5Y3.46%
EBIT Next Year15.64%
EBIT Next 3Y10.13%
EBIT Next 5YN/A
FCF growth 1Y-80.63%
FCF growth 3Y31.21%
FCF growth 5Y-1.32%
OCF growth 1Y-51.9%
OCF growth 3Y25.56%
OCF growth 5Y2.69%

INNOSPEC INC / IOSP FAQ

Can you provide the ChartMill fundamental rating for INNOSPEC INC?

ChartMill assigns a fundamental rating of 5 / 10 to IOSP.


Can you provide the valuation status for INNOSPEC INC?

ChartMill assigns a valuation rating of 4 / 10 to INNOSPEC INC (IOSP). This can be considered as Fairly Valued.


What is the profitability of IOSP stock?

INNOSPEC INC (IOSP) has a profitability rating of 5 / 10.


Can you provide the financial health for IOSP stock?

The financial health rating of INNOSPEC INC (IOSP) is 8 / 10.


Can you provide the expected EPS growth for IOSP stock?

The Earnings per Share (EPS) of INNOSPEC INC (IOSP) is expected to decline by -9.9% in the next year.